schizophrenia
SCHIZOPHRENIA
Schizophrenia is a devastating mental illness characterized by symptoms eg hallucinations, disorganized thinking, loss of goal-directed behaviors and deterioration in social role functioning.
Positive or psychotic symptoms are delusions, hallucinations, and distorted perceptions.
Negative symptoms include flat or blunted emotions, lack of motivation or energy, lack of pleasure or interest in things, and limited speech.
Disorganized symptoms are confused thinking, disorganized speech and behavior.
Cognitive symptoms include impairment in attention verbal fluency memory, and executive functioning.

Schizophrenia Drug Information

Drug Information

Indication: Maintenance treatment of schizophrenia in adult patients.

Indication: Schizophrenia. Mono- & adjunct therapy for acute treatment of manic or mixed episodes associated w/ bipola...

Indication: Patients w/ schizophrenia who are non-responsive to or intolerant of classic antipsychotics. Recurrent suicida...

Indication: Schizophrenia in adolescents ≥15 yr including acute treatment & recurrence prevention. Acute exacerbati...

Indication: Acute & maintenance treatment of schizophrenia in adults. Schizoaffective disorder in adults as monotherap...

Indication: Risperdal Schizophrenia including 1st episode psychoses, acute schizophrenic exacerbations, chronic schizophre...

Indication: Acute & maintenance treatment of schizoprenia. Acute manic episodes associated w/ bipolar I disorder.

Indication: Schizophrenia & acute manic episodes w/ bipolar I disorder.

Dosage: ...Clopixol oral drops Acute schizophrenia & other acute psychoses, severe acute state of agitation &...

Indication: Schizophrenia & allied psychoses, especially w/ symptoms eg, hallucinations, paranoid delusions & thou...

1  /  5
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Dr Margaret Shi, 3 days ago

A recent cross-sectional study shows that the mental health burden (ie, symptoms of depression, anxiety, insomnia, acute stress) associated with coronavirus disease 2019 (COVID-19) is considerable in China, particularly among individuals with confirmed or suspected COVID-19 and those exposed to patients with COVID-19 at work.